Hyperthyroidism: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Subpagination Bot m (Add {{subpages}} and remove any categories (details)) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
==Treatment== | ==Treatment== | ||
===Medical=== | ===Medical=== | ||
| Line 5: | Line 7: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 16:19, 3 November 2007
Treatment
Medical
For patients treated medically, methimazole is the first choice medication. [1] Methimazole 15 mg by mouth once per day will normalize the free T4 in 86% of patients with less liver toxicity than propylthiouracil.
References
- ↑ Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N (2007). "Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by graves' disease". J. Clin. Endocrinol. Metab. 92 (6): 2157-62. DOI:10.1210/jc.2006-2135. PMID 17389704. PMID 17389704. Research Blogging.